EDITAS MEDICINE, INC.;JUNO THERAPEUTICS; INC.;JUNO THERAPEUTICS, INC.
发明人:
SATHER, BLYTHE,WELSTEAD, G. GRANT,BUMCROT, DAVID A.,FRIEDLAND, ARI E.,JONES, JON,MAEDER, MORGAN L.,NYE, CHRIS,RUBIO, EUGENIO MARCO,SALMON, RUTH
申请号：
CA3022611
公开号：
CA3022611A1
申请日:
2017.05.06
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Provided are CRIS PR/CAS -related methods, compositions and components for editing a target nucleic acid sequence, or modulating expression of a target nucleic acid sequence, and applications thereof in connection with cancer immunotherapy comprising adoptive transfer of engineered T cells or T cell precursors.
